stella
beta
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach — Stella
Home
/
Pancreatic Cancer
/
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
View on ClinicalTrials.gov
Recruiting
Back to Pancreatic Cancer trials
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(3 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama
Washington University, St. Louis, St Louis, Missouri
UH Cleveland Medical Center, Cleveland, Ohio
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow